49 related articles for article (PubMed ID: 25930743)
1. NOTCH1-Induced T-Cell Acute Lymphoblastic Leukemia In Vivo Models.
Campagnari A; Belver L
Methods Mol Biol; 2024; 2773():9-24. PubMed ID: 38236532
[TBL] [Abstract][Full Text] [Related]
2. The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia.
Gianni F; Belver L; Ferrando A
Cold Spring Harb Perspect Med; 2020 Mar; 10(3):. PubMed ID: 31570389
[TBL] [Abstract][Full Text] [Related]
3. NOTCH1-driven UBR7 stimulates nucleotide biosynthesis to promote T cell acute lymphoblastic leukemia.
Srivastava S; Sahu U; Zhou Y; Hogan AK; Sathyan KM; Bodner J; Huang J; Wong KA; Khalatyan N; Savas JN; Ntziachristos P; Ben-Sahra I; Foltz DR
Sci Adv; 2021 Jan; 7(5):. PubMed ID: 33571115
[TBL] [Abstract][Full Text] [Related]
4. Lineage switching of the cellular distribution of BRAFV600E in multisystem Langerhans cell histiocytosis.
Milne P; Bomken S; Slater O; Kumar A; Nelson A; Roy S; Velazquez J; Mankad K; Nicholson J; Yeomanson D; Grundy R; Kamal A; Penn A; Pears J; Millen G; Morland B; Hayden J; Lam J; Madkhali M; MacDonald J; Singh P; Pagan S; Rodriguez-Galindo C; Minkov M; Donadieu J; Picarsic J; Allen C; Bigley V; Collin M
Blood Adv; 2023 May; 7(10):2171-2176. PubMed ID: 36112425
[TBL] [Abstract][Full Text] [Related]
5. Noncoding mutations drive persistence of a founder preleukemic clone which initiates late relapse in T-ALL.
O'Connor D; Valle-Inclán JE; Conde L; Bloye G; Rahman S; Costa JR; Bartram J; Adams S; Wright G; Elrick H; Wall K; Dyer S; Howell C; Jigoulina G; Herrero J; Cortes-Ciriano I; Moorman AV; Mansour MR
Blood; 2024 Mar; 143(10):933-937. PubMed ID: 38194681
[TBL] [Abstract][Full Text] [Related]
6. Characterization of LEF1 High Expression and Novel Mutations in Adult Acute Lymphoblastic Leukemia.
Guo X; Zhang R; Liu J; Li M; Song C; Dovat S; Li J; Ge Z
PLoS One; 2015; 10(5):e0125429. PubMed ID: 25942645
[TBL] [Abstract][Full Text] [Related]
7. Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.
Gatalica Z; Bilalovic N; Palazzo JP; Bender RP; Swensen J; Millis SZ; Vranic S; Von Hoff D; Arceci RJ
Oncotarget; 2015 Aug; 6(23):19819-25. PubMed ID: 26110571
[TBL] [Abstract][Full Text] [Related]
8. Reprogramming of B cell acute lymphoblastic leukemia cells: Do we need to shoot a moving target?
Fišer K; Slámová L; Bourquin JP; Trka J; Starý J; Hrušák O; Mejstříková E
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3455. PubMed ID: 26069210
[No Abstract] [Full Text] [Related]
9. Dicer1 imparts essential survival cues in Notch-driven T-ALL via miR-21-mediated tumor suppressor Pdcd4 repression.
Junker F; Chabloz A; Koch U; Radtke F
Blood; 2015 Aug; 126(8):993-1004. PubMed ID: 25979949
[TBL] [Abstract][Full Text] [Related]
10. CDKN2A/B Deletion and Double-hit Mutations of the MAPK Pathway Underlie the Aggressive Behavior of Langerhans Cell Tumors.
Xerri L; Adélaïde J; Popovici C; Garnier S; Guille A; Mescam-Mancini L; Laurent C; Brousset P; Coze C; Michel G; Chaffanet M; Bouabdallah R; Coso D; Bertucci F; Birnbaum D
Am J Surg Pathol; 2018 Feb; 42(2):150-159. PubMed ID: 29194093
[TBL] [Abstract][Full Text] [Related]
11. Langerhans cell histiocytosis developing acute lymphoblastic leukemia.
Zhang J; Zong S; Liao B
SAGE Open Med Case Rep; 2022; 10():2050313X221080328. PubMed ID: 35237442
[TBL] [Abstract][Full Text] [Related]
12. Histiocytic disorders.
McClain KL; Bigenwald C; Collin M; Haroche J; Marsh RA; Merad M; Picarsic J; Ribeiro KB; Allen CE
Nat Rev Dis Primers; 2021 Oct; 7(1):73. PubMed ID: 34620874
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation.
Kemps PG; Hebeda KM; Pals ST; Verdijk RM; Lam KH; Bruggink AH; de Lil HS; Ruiterkamp B; de Heer K; van Laar JA; Valk PJ; Mutsaers P; Levin MD; Hogendoorn PC; van Halteren AG
J Pathol Clin Res; 2021 Jan; 7(1):10-26. PubMed ID: 32852896
[TBL] [Abstract][Full Text] [Related]
14. NOTCH1 pathway activating mutations and clonal evolution in pediatric T-cell acute lymphoblastic leukemia.
Kimura S; Seki M; Yoshida K; Shiraishi Y; Akiyama M; Koh K; Imamura T; Manabe A; Hayashi Y; Kobayashi M; Oka A; Miyano S; Ogawa S; Takita J
Cancer Sci; 2019 Feb; 110(2):784-794. PubMed ID: 30387229
[TBL] [Abstract][Full Text] [Related]
15. Non-neoplastic histiocytic and dendritic cell disorders in lymph nodes.
Egan C; Jaffe ES
Semin Diagn Pathol; 2018 Jan; 35(1):20-33. PubMed ID: 29150219
[TBL] [Abstract][Full Text] [Related]
16. Unique clonal relationship between T-cell acute lymphoblastic leukemia and subsequent Langerhans cell histiocytosis with TCR rearrangement and NOTCH1 mutation.
Yokokawa Y; Taki T; Chinen Y; Kobayashi S; Nagoshi H; Akiyama M; Morimoto A; Ida H; Taniwaki M
Genes Chromosomes Cancer; 2015 Jul; 54(7):409-17. PubMed ID: 25930743
[TBL] [Abstract][Full Text] [Related]
17. Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1.
Rodig SJ; Payne EG; Degar BA; Rollins B; Feldman AL; Jaffe ES; Androkites A; Silverman LB; Longtine JA; Kutok JL; Fleming MD; Aster JC
Am J Hematol; 2008 Feb; 83(2):116-21. PubMed ID: 17874453
[TBL] [Abstract][Full Text] [Related]
18. Detection of clonal lymphoid receptor gene rearrangements in langerhans cell histiocytosis.
Chen W; Wang J; Wang E; Lu Y; Lau SK; Weiss LM; Huang Q
Am J Surg Pathol; 2010 Jul; 34(7):1049-57. PubMed ID: 20551822
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathologic features and prognosis of T lymphoblastic lymphoma associated with Langerhans cell histiocytosis].
Li X; Wang Y; Chen R; Abulaiti D; Ma Z; Miao N; Abulajiang G; Zhang W
Zhonghua Bing Li Xue Za Zhi; 2014 Aug; 43(8):522-7. PubMed ID: 25346121
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
